Trials / Sponsors / Tarapeutics Science Inc.
Tarapeutics Science Inc.
Industry · 5 registered clinical trials — 5 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Recruiting | TR128 in Patients With Advanced Solid Tumors Advanced Solid Tumor | Phase 1 | 2024-02-23 |
| Recruiting | TR115 in Patients With Relapsed / Refractory Non-Hodgkin's Lymphoma or Advanced Solid Tumors Non-Hodgkin's Lymphoma, Relapsed, Non-Hodgkin's Lymphoma Refractory, Advanced Solid Tumor | Phase 1 | 2023-04-23 |
| Recruiting | TR64 in Patients With Advanced Solid Tumors Advanced Solid Tumor | Phase 1 | 2023-01-12 |
| Recruiting | A Study of HYML-122 and Cytarabine in Patients With FLT3 Positive Relapsed or Refractory Acute Myeloid Leukemi Relapsed or Refractory Acute Myeloid Leukemia (AML) | Phase 2 | 2022-03-29 |
| Recruiting | A Study of HYML-122 in Patients With FLT3 Positive Relapsed or Refractory Acute Myeloid Leukemia (AML) Relapsed or Refractory Acute Myeloid Leukemia (AML) | Phase 2 | 2021-09-29 |